Gilead Sciences Inc Xilio Therapeutics, Inc. (XLO) insider trading activity

XLO Quotes by TradingView

Gilead Sciences Inc is > 10% Shareholder of Xilio Therapeutics, Inc.. Currently has a direct ownership of 7.35 Million shares of XLO, which is worth approximately $6.61 Million. The most recent transaction as insider was on Apr 02, 2024, when has been sold 485,250 shares (Common Stock) at a price of $0.76 per share, resulting in proceeds of $368,790. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.35M
n/a 3M change
n/a 12M change
Total Value Held $6.61 Million

GILEAD SCIENCES INC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 02 2024
BUY
Open market or private purchase
$368,790 $0.76 p/Share
485,250 Added 6.2%
7,345,473 Common Stock

Also insider at

RCUS
Arcus Biosciences, Inc. Healthcare
> 10% Shareholder
ALVR
Allovir, Inc. Healthcare
> 10% Shareholder
KYTX
Kyverna Therapeutics, Inc.
> 10% Shareholder
ASMB
ASSEMBLY BIOSCIENCES, INC. Healthcare
> 10% Shareholder
GSI

Gilead Sciences Inc

> 10% Shareholder
Foster City, CA

Track Institutional and Insider Activities on XLO

Follow Xilio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XLO shares.

Notify only if

Insider Trading

Get notified when an Xilio Therapeutics, Inc. insider buys or sells XLO shares.

Notify only if

News

Receive news related to Xilio Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XLO